Brendan J. Brodeur’s practice includes a range of securities and complex commercial litigation matters involving allegations of fraud, deceptive business practices, and breach of contract. In addition to prosecuting claims on behalf of institutional investors, he advises and defends financial services and biotechnology firms in response to governmental investigations of suspected violations of securities laws.
Brendan Brodeur concentrates his practice on securities litigation and complex commercial disputes. Mr. Brodeur’s work primarily involves legal research and drafting complaints, letters and motions. Mr. Brodeur also has extensive experience handling all aspects of discovery, including deposing senior executives at large public companies. Most recently, Mr. Brodeur was a key participant in the In re Alta Mesa Resources, Inc. Securities Litigation jury trial, which settled after three weeks of trial and resulted in a $126.3 million recovery on behalf of investors.
After earning a B.A. in Biology from Tufts University College of Arts and Sciences, Mr. Brodeur spent two years developing vaccines at a not-for- profit biomedical research institute. He then earned a J.D. cum laude from Northwestern University School of Law, where he was a Senior Articles Editor for the Journal of Criminal Law and Criminology. Prior to joining E&C, Mr. Brodeur worked for five years as a litigation associate at Skadden, Arps, Slate, Meagher & Flom LLP.
Practices
Education
- Northwestern University School of Law, J.D., cum laude
- Tufts University College of Arts and Sciences, B.A.
Bar Admissions
- New York
- Massachusetts